BIOGEN INC (IDP.DE) Stock Fundamental Analysis
FRA:IDP - Deutsche Boerse Ag - US09062X1037 - Common Stock - Currency: EUR
Overall IDP gets a fundamental rating of 5 out of 10. We evaluated IDP against 72 industry peers in the Biotechnology industry. IDP scores excellent on profitability, but there are some minor concerns on its financial health. IDP is valued quite cheap, but it does not seem to be growing. These ratings would make IDP suitable for value investing!
1. Profitability
1.1 Basic Checks
IDP had positive earnings in the past year.
In the past year IDP had a positive cash flow from operations.
In the past 5 years IDP has always been profitable.
In the past 5 years IDP always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.82%, IDP belongs to the top of the industry, outperforming 90.28% of the companies in the same industry.
The Return On Equity of IDP (9.76%) is better than 86.11% of its industry peers.
IDP has a Return On Invested Capital of 9.92%. This is amongst the best in the industry. IDP outperforms 86.11% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IDP is in line with the industry average of 11.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.82% | ||
| ROE | 9.76% | ||
| ROIC | 9.92% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
1.3 Margins
Looking at the Profit Margin, with a value of 16.87%, IDP belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
IDP's Profit Margin has declined in the last couple of years.
IDP has a Operating Margin of 26.35%. This is amongst the best in the industry. IDP outperforms 88.89% of its industry peers.
In the last couple of years the Operating Margin of IDP has declined.
IDP has a better Gross Margin (76.12%) than 76.39% of its industry peers.
In the last couple of years the Gross Margin of IDP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.35% | ||
| PM (TTM) | 16.87% | ||
| GM | 76.12% |
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
IDP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, IDP has more shares outstanding
IDP has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IDP has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.87 indicates that IDP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.87, IDP is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
The Debt to FCF ratio of IDP is 2.50, which is a good value as it means it would take IDP, 2.50 years of fcf income to pay off all of its debts.
IDP has a Debt to FCF ratio of 2.50. This is amongst the best in the industry. IDP outperforms 91.67% of its industry peers.
IDP has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
IDP has a better Debt to Equity ratio (0.27) than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.5 | ||
| Altman-Z | 2.87 |
ROIC/WACC1.12
WACC8.83%
2.3 Liquidity
A Current Ratio of 1.35 indicates that IDP should not have too much problems paying its short term obligations.
IDP's Current ratio of 1.35 is on the low side compared to the rest of the industry. IDP is outperformed by 66.67% of its industry peers.
IDP has a Quick Ratio of 1.35. This is a bad value and indicates that IDP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.90, IDP is not doing good in the industry: 63.89% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
IDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.22%, which is quite good.
The earnings per share for IDP have been decreasing by -13.31% on average. This is quite bad
Looking at the last year, IDP shows a decrease in Revenue. The Revenue has decreased by -1.62% in the last year.
IDP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.62% yearly.
EPS 1Y (TTM)9.22%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%4.24%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%2.87%
3.2 Future
Based on estimates for the next years, IDP will show a small growth in Earnings Per Share. The EPS will grow by 3.73% on average per year.
The Revenue is expected to grow by 1.31% on average over the next years.
EPS Next Y-1.84%
EPS Next 2Y-1.03%
EPS Next 3Y1.97%
EPS Next 5Y3.73%
Revenue Next Year-4.58%
Revenue Next 2Y-2.56%
Revenue Next 3Y-0.87%
Revenue Next 5Y1.31%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
IDP is valuated reasonably with a Price/Earnings ratio of 9.25.
IDP's Price/Earnings ratio is rather cheap when compared to the industry. IDP is cheaper than 97.22% of the companies in the same industry.
When comparing the Price/Earnings ratio of IDP to the average of the S&P500 Index (29.35), we can say IDP is valued rather cheaply.
IDP is valuated reasonably with a Price/Forward Earnings ratio of 9.43.
94.44% of the companies in the same industry are more expensive than IDP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, IDP is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.25 | ||
| Fwd PE | 9.43 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IDP is valued cheaper than 88.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IDP is valued cheaper than 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.87 | ||
| EV/EBITDA | 8.14 |
4.3 Compensation for Growth
The decent profitability rating of IDP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.03%
EPS Next 3Y1.97%
5. Dividend
5.1 Amount
IDP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:IDP (3/7/2025, 7:00:00 PM)
140.35
+6.9 (+5.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners94.24%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap20.54B
Analysts74.42
Price Target191.38 (36.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.08%
Min EPS beat(2)0.67%
Max EPS beat(2)5.5%
EPS beat(4)4
Avg EPS beat(4)9.77%
Min EPS beat(4)0.67%
Max EPS beat(4)28.61%
EPS beat(8)8
Avg EPS beat(8)6.83%
EPS beat(12)11
Avg EPS beat(12)8.87%
EPS beat(16)14
Avg EPS beat(16)9.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.68%
Max Revenue beat(2)0.11%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-2.86%
Max Revenue beat(4)1.48%
Revenue beat(8)5
Avg Revenue beat(8)0.17%
Revenue beat(12)7
Avg Revenue beat(12)0.42%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)-13.79%
PT rev (3m)-21.08%
EPS NQ rev (1m)-7.39%
EPS NQ rev (3m)-7.75%
EPS NY rev (1m)-4.49%
EPS NY rev (3m)-5.16%
Revenue NQ rev (1m)-1.96%
Revenue NQ rev (3m)-3.37%
Revenue NY rev (1m)-2.57%
Revenue NY rev (3m)-3.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.25 | ||
| Fwd PE | 9.43 | ||
| P/S | 2.31 | ||
| P/FCF | 8.87 | ||
| P/OCF | 7.76 | ||
| P/B | 1.33 | ||
| P/tB | 40.86 | ||
| EV/EBITDA | 8.14 |
EPS(TTM)15.17
EY10.81%
EPS(NY)14.89
Fwd EY10.61%
FCF(TTM)15.83
FCFY11.28%
OCF(TTM)18.09
OCFY12.89%
SpS60.89
BVpS105.19
TBVpS3.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.82% | ||
| ROE | 9.76% | ||
| ROCE | 11.32% | ||
| ROIC | 9.92% | ||
| ROICexc | 11.09% | ||
| ROICexgc | 56.18% | ||
| OM | 26.35% | ||
| PM (TTM) | 16.87% | ||
| GM | 76.12% | ||
| FCFM | 26% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
ROICexc(3y)12.43%
ROICexc(5y)16.11%
ROICexgc(3y)38.35%
ROICexgc(5y)40.12%
ROCE(3y)12.07%
ROCE(5y)15.58%
ROICexcg growth 3Y14.15%
ROICexcg growth 5Y-5.35%
ROICexc growth 3Y-15.93%
ROICexc growth 5Y-20.8%
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
F-Score6
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.5 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 53.45% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 10.39 | ||
| Cash Conversion | 89.23% | ||
| Profit Quality | 154.13% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 2.87 |
F-Score6
WACC8.83%
ROIC/WACC1.12
Cap/Depr(3y)54.43%
Cap/Depr(5y)68.89%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.21%
Profit Quality(3y)99.34%
Profit Quality(5y)120.98%
High Growth Momentum
Growth
EPS 1Y (TTM)9.22%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%4.24%
EPS Next Y-1.84%
EPS Next 2Y-1.03%
EPS Next 3Y1.97%
EPS Next 5Y3.73%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%2.87%
Revenue Next Year-4.58%
Revenue Next 2Y-2.56%
Revenue Next 3Y-0.87%
Revenue Next 5Y1.31%
EBIT growth 1Y24.37%
EBIT growth 3Y-8.8%
EBIT growth 5Y-18.9%
EBIT Next Year19.92%
EBIT Next 3Y18.74%
EBIT Next 5Y0.74%
FCF growth 1Y103.57%
FCF growth 3Y-9.06%
FCF growth 5Y-17.06%
OCF growth 1Y85.85%
OCF growth 3Y-7.56%
OCF growth 5Y-16.49%